NMRA · Neumora Therapeutics, Inc.
The AI's read
The pipeline updates show progress, but they do not settle how well these treatments will work in people. NMRA-511's new results came from healthy older adults, and NMRA-215's weight-loss findings came from mice. Neumora also says it needs substantial new funding and gave no updated estimate of how long its cash will last. These facts leave no clear change in its outlook.